These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8782667)

  • 1. The potent anti-proliferative effect of 20-epi analogues of 1,25 dihydroxyvitamin D3 in human breast-cancer MCF-7 cells is related to promoter selectivity.
    Mørk Hansen C; Danielsson C; Carlberg C
    Int J Cancer; 1996 Sep; 67(5):739-42. PubMed ID: 8782667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-affinity nuclear receptor binding of 20-epi analogues of 1,25-dihydroxyvitamin D3 correlates well with gene activation.
    Nayeri S; Mathiasen IS; Binderup L; Carlberg C
    J Cell Biochem; 1996 Sep; 62(3):325-33. PubMed ID: 8872604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity.
    Nayeri S; Danielsson C; Kahlen JP; Schräder M; Mathiasen IS; Binderup L; Carlberg C
    Oncogene; 1995 Nov; 11(9):1853-8. PubMed ID: 7478614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity.
    Quack M; Clarin A; Binderup E; Björkling F; Hansen CM; Carlberg C
    J Cell Biochem; 1998 Dec; 71(3):340-50. PubMed ID: 9831071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.
    Vink-van Wijngaarden T; Pols HA; Buurman CJ; van den Bemd GJ; Dorssers LC; Birkenhäger JC; van Leeuwen JP
    Cancer Res; 1994 Nov; 54(21):5711-7. PubMed ID: 7923220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity.
    Danielsson C; Mathiasen IS; James SY; Nayeri S; Bretting C; Hansen CM; Colston KW; Carlberg C
    J Cell Biochem; 1997 Sep; 66(4):552-62. PubMed ID: 9282333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent gene regulatory and antiproliferative activities of 20-methyl analogues of 1,25 dihydroxyvitamin D3.
    Danielsson C; Nayeri S; Wiesinger H; Thieroff-Ekerdt R; Carlberg C
    J Cell Biochem; 1996 Nov; 63(2):199-206. PubMed ID: 8913871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential apoptotic response of human melanoma cells to 1 alpha,25-dihydroxyvitamin D3 and its analogues.
    Danielsson C; Fehsel K; Polly P; Carlberg C
    Cell Death Differ; 1998 Nov; 5(11):946-52. PubMed ID: 9846181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the vitamin D3 analogue EB1089 alters receptor complex formation and reduces promoter selectivity.
    Quack M; Mørk Hansen C; Binderup E; Kissmeyer AM; Carlberg C
    Br J Pharmacol; 1998 Oct; 125(4):607-14. PubMed ID: 9831892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of a novel type of 1 alpha,25-dihydroxyvitamin D3 response element identified in the mouse c-fos promoter.
    Schräder M; Kahlen JP; Carlberg C
    Biochem Biophys Res Commun; 1997 Jan; 230(3):646-51. PubMed ID: 9015378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition of human breast cancer cells by 1,25-dihydroxyvitamin D3 is accompanied by induction of apolipoprotein D expression.
    López-Boado YS; Puente XS; Alvarez S; Tolivia J; Binderup L; López-Otín C
    Cancer Res; 1997 Sep; 57(18):4091-7. PubMed ID: 9307298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.
    Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Uskokovic MR; Brenner RV; Evans SR
    Cancer Res; 1994 Aug; 54(15):4057-64. PubMed ID: 8033137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
    Elstner E; Linker-Israeli M; Said J; Umiel T; de Vos S; Shintaku IP; Heber D; Binderup L; Uskokovic M; Koeffler HP
    Cancer Res; 1995 Jul; 55(13):2822-30. PubMed ID: 7796409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: cis-perhydrindane CE-ring analogues.
    Demin S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R; Verstuyf A
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3885-8. PubMed ID: 15225690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative activity in vitro of side-chain analogues of calcitriol against various human normal and cancer cell lines.
    Opolski A; Wietrzyk J; Chrobak A; Marcinkowska E; Wojdat E; Kutner A; Radzikowski C
    Anticancer Res; 1999; 19(6B):5217-22. PubMed ID: 10697538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo.
    Verlinden L; Verstuyf A; Van Camp M; Marcelis S; Sabbe K; Zhao XY; De Clercq P; Vandewalle M; Bouillon R
    Cancer Res; 2000 May; 60(10):2673-9. PubMed ID: 10825140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.